NDC codes

FDA NDC Directory
Product NDC (as listed)55154-4314Labeler and product segments. Claims need a package NDC.
Product NDC at billing width55154-4314Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
55154-4314-5551544314055 CUP, UNIT-DOSE in 1 BAG (55154-4314-5) / 5 mL in 1 CUP, UNIT-DOSEMarketed from Aug 1, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Nystatin
Generic name (nonproprietary)
nystatin
Active ingredients
Nystatin — 100000 [USP'U]/mL
Dosage form
Suspension
Route
Oral
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 203621
Marketing start
Listing expires
Other FDA classes
Polyenes (Chemical structure)
Identifiers
Product ID 55154-4314_c6dbde35-e0a0-4f55-be3e-471aeb0b0302SPL ID c6dbde35-e0a0-4f55-be3e-471aeb0b0302SPL set ID 56aca0e2-8691-4701-beba-e2315524709fRxCUI 312055UNII BDF1O1C72EUPC 0055154431453
Pharmacologic class
Polyene Antifungal

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N455154431405 followed by a unit qualifier and the quantity

Package 55154-4314-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

INDICATIONS AND USAGE Nystatin Oral Suspension is indicated for the treatment of candidiasis in the oral cavity.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 203621

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203621
ProductStrengthForm · routeLabelerProduct NDC
NystatinNystatin 100000 [USP'U]/mLSuspensionOralAmerican Health Packaging60687-800
NystatinNystatin 100000 [USP'U]/mLSuspensionOralPAI Holdings, LLC dba PAI Pharma0121-0868
NystatinNystatin 100000 [USP'U]/mLSuspensionOralA-S Medication Solutions50090-5315
NystatinNystatin 100000 [USP'U]/mLSuspensionOralMajor Pharmaceuticals0904-7276
NystatinNystatin 100000 [USP'U]/mLSuspensionOralPharmaceutical Associates, Inc.0121-0810
NystatinNystatin 100000 [USP'U]/mLSuspensionOralCardinal Health 107, LLC55154-5788
NystatinNystatin 100000 [USP'U]/mLSuspensionOralPharmaceutical Associates, Inc.0121-4810

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in